Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
ePTFE‐covered stents may leads to lower all‐cause mortality compared with bare stents (low certainty).
It is very uncertain whether ePTFE‐covered stents changes hepatic encephalopathy compared with bare stents (very low certainty).
It is very uncertain whether ePTFE‐covered stents changes kidney failure compared with bare stents (very low certainty).
ePTFE‐covered stents may leads to lower shunt dysfunctiona compared with bare stents (low certainty).
ePTFE‐covered stents may leads to lower upper gastrointestinal bleeding compared with bare stents (low certainty).
ePTFE‐covered stents may leads to lower recurrence of ascites compared with bare stents (low certainty).
ePTFE‐covered stents may leads to lower shunt dysfunction compared with bare stents (low certainty).
It is very uncertain whether ePTFE‐covered stents changes all‐cause mortalitya compared with bare stents (very low certainty).
It is very uncertain whether ePTFE‐covered stents changes procedure‐related complications compared with bare stents (very low certainty).
Vaginal procedure probably leads to higher awareness of prolapse compared with sacral colpopexy (vault prolapse) (moderate certainty).
Vaginal hysterectomy showed no clear difference in surgery for recurrent prolapse compared with sacral hysteropexy/cervicopexy (uterine prolapse) (low certainty).
Vaginal hysterectomy showed no clear difference in prolapse on examination (Stage 2 or greater) ‐ Any recurrent prolapse compared with sacral hysteropexy/cervicopexy (uterine prolapse) (moderate certainty).
It is very uncertain whether vaginal hysterectomy changes mesh exposure compared with sacral hysteropexy/cervicopexy (uterine prolapse) (very low certainty).
Vaginal hysteropexy showed no clear difference in awareness of prolapse compared with sacral hysteropexy (uterine prolapse) (low certainty).
Vaginal hysteropexy showed no clear difference in surgery for recurrent prolapse compared with sacral hysteropexy (uterine prolapse) (moderate certainty).
Vaginal hysteropexy showed no clear difference in prolapse on examination (Stage 2 or above) ‐ Any recurrent prolapse compared with sacral hysteropexy (uterine prolapse) (moderate certainty).
It is very uncertain whether vaginal hysteropexy changes mesh exposure (1‐4 years) compared with sacral hysteropexy (uterine prolapse) (very low certainty).